112 related articles for article (PubMed ID: 18608871)
1. The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.
Robak P; Smolewski P; Robak T
Leuk Lymphoma; 2008 Aug; 49(8):1452-62. PubMed ID: 18608871
[TBL] [Abstract][Full Text] [Related]
2. SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma.
Lentzsch S; Elliott G; Roodman GD
Arch Pharm (Weinheim); 2007 Oct; 340(10):511-6. PubMed ID: 17849446
[TBL] [Abstract][Full Text] [Related]
3. Treatment of multiple myeloma with SDX-308.
Feng R; Lentzsch S
Drug News Perspect; 2007 Sep; 20(7):431-5. PubMed ID: 17992265
[TBL] [Abstract][Full Text] [Related]
4. R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
Lindhagen E; Nissle S; Leoni L; Elliott G; Chao Q; Larsson R; Aleskog A
Cancer Chemother Pharmacol; 2007 Sep; 60(4):545-53. PubMed ID: 17186240
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro.
Lindhagen E; Rickardson L; Elliott G; Leoni L; Nygren P; Larsson R; Aleskog A
Invest New Drugs; 2007 Aug; 25(4):297-303. PubMed ID: 17440681
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Robak P; Linke A; Cebula B; Robak T; Smolewski P
Leuk Lymphoma; 2006 Dec; 47(12):2625-34. PubMed ID: 17169808
[TBL] [Abstract][Full Text] [Related]
7. Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway.
Yasui H; Hideshima T; Ikeda H; Ocio EM; Kiziltepe T; Vallet S; Okawa Y; Neri P; Sukhdeo K; Podar K; Chauhan D; Richardson PG; Raje N; Carrasco DR; Anderson KC
Leukemia; 2007 Mar; 21(3):535-40. PubMed ID: 17268521
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study.
Walter RB; Milano F; Brasky TM; White E
J Clin Oncol; 2011 Jun; 29(17):2424-31. PubMed ID: 21555699
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
10. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Colebatch AN; Marks JL; Edwards CJ
Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
[TBL] [Abstract][Full Text] [Related]
11. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee.
Watson MC; Brookes ST; Kirwan JR; Faulkner A
Cochrane Database Syst Rev; 2000; (2):CD000142. PubMed ID: 10796306
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
Auriel E; Regev K; Korczyn AD
Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
Asero R
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.
Genkinger JM; De Vivo I; Stampfer MJ; Giovannucci E; Michaud DS
Int J Cancer; 2007 May; 120(10):2221-5. PubMed ID: 17290403
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and NSAIDs: effects in breast and ovarian cancers.
Crew KD; Neugut AI
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
[TBL] [Abstract][Full Text] [Related]
18. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
Rahme E; Ghosn J; Dasgupta K; Rajan R; Hudson M
BMC Cancer; 2005 Dec; 5():159. PubMed ID: 16343343
[TBL] [Abstract][Full Text] [Related]
19. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
Hohlfeld T; Saxena A; Schrör K
Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
[TBL] [Abstract][Full Text] [Related]
20. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
